References
- B. Sibai, G. Dekker and M. Kupferminc, Pre-eclampsia, The Lancet 365(9461) (2005) 785–799; https://doi.org/10.1016/S0140-6736(05)17987-2
- L. C. Poon, A. Shennan, J. A. Hyett, A. Kapur, E. Hadar, H. Divakar, F. McAuliffe, F. Silva Costa, P. Dadelszen, H. D. McIntyre, A. B. Kihara, G. C. Di Renzo, R. Romero, M. D’Alton, V. Berghella, K. H. Nicolaides and M. Hod, The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention, Int. J. Gynecol. Obstet. 145(S1) (2019) 1–33; https://doi.org/10.1002/ijgo.12802
- Gestational Hypertension and Preeclampsia ACOG Practice Bulletin, Number 222, Obstet. Gynecol. 135(6) (2020) e237–e260; https://doi.org/10.1097/AOG.0000000000003891
- National Guideline Alliance (Great Britain), Hypertension in pregnancy: Diagnosis and management, NICE Guideline 2023; https://doi.org/www.nice.org.uk/guidance/ng133.
- L. A. Magee, M. A. Brown, D. R. Hall, S. Gupte, A. Hennessy, S. A. Karumanchi, L. C. Kenny, F. McCarthy, J. Myers, L. C. Poon, S. Rana, S. Saito, A. C. Staff, E. Tsigas and P. von Dadelszen, The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice, Pregnancy Hypertension 27 (2022) 148–169; https://doi.org/10.1016/j.preghy.2021.09.008
- E. Dimitriadis, D. L. Rolnik, W. Zhou, G. Estrada-Gutierrez, K. Koga, R. P. V. Francisco, C. White-head, J. Hyett, F. Da Silva Costa, K. Nicolaides and E. Menkhorst, Pre-eclampsia, Nat. Rev. Dis. Primers 9(1) (2023) Article ID 8 (22 pages); https://doi.org/10.1038/s41572-023-00417-6
- C. W. Ives, R. Sinkey, I. Rajapreyar, A. T. N. Tita and S. Oparil, Preeclampsia – pathophysiology and clinical presentations, J. Am. College Cardiol. 76(14) (2020) 1690–1702; https://doi.org/10.1016/j.jacc.2020.08.014
- H. Stepan, M. Hund and T. Andraczek, Combining biomarkers to predict pregnancy complications and redefine preeclampsia: The angiogenic-placental syndrome, Hypertension 75(4) (2020) 918–926; https://doi.org/10.1161/HYPERTENSIONAHA.119.13763
- K. H. Nicolaides, D. Wright, A. Syngelaki, A. Wright and R. Akolekar, Fetal Medicine Foundation fetal and neonatal population weight charts, Ultrasound Obstet. Gynecol. 52(1) (2018) 44–51; https://doi.org/10.1002/uog.19073
- S. Verlohren, I. Herraiz, O. Lapaire, D. Schlembach, H. Zeisler, P. Calda, J. Sabria, F. Markfeld-Erol, A. Galindo, K. Schoofs, B. Denk and H. Stepan, New gestational phase-specific cut-off values for the use of the soluble fms-like tyrosine kinase-1/Placental growth factor ratio as a diagnostic test for preeclampsia, Hypertension 63(2) (2014) 346–352; https://doi.org/10.1161/HYPERTENSIONAHA.113.01787
- International Association of Diabetes and Pregnancy Study Groups Consensus Panel, International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy, Diabetes Care 33(3) (2010) 676–682; https://doi.org/10.2337/dc09-1848
- A. M. Nuzzo, D. Giuffrida, L. Moretti, P. Re, G. Grassi, G. Menato and A. Rolfo, Placental and maternal sFlt1/PlGF expression in gestational diabetes mellitus, Sci. Rep. 11(1) (2021) Article ID 2312 (10 pages); https://doi.org/10.1038/s41598-021-81785-5
- T. Elawad, G. Scott, J. N. Bone, H. Elwell, C. E. Lopez, V. Filippi, M. Green, A. Khalil, M. W. Kinshella, H. D. Mistry, K. Pickerill, R. Shanmugam, J. Singer, R. Townsend, E. Z. Tsigas, M. Vidler, M. L. Volvert, P. von Dadelszen and L. A. Magee, Risk factors for pre-eclampsia in clinical practice guidelines: Comparison with the evidence, BJOG (2022) 46–62; https://doi.org/10.1111/1471-0528.17320
- R. Townsend, A. Khalil, Y. Premakumar, J. Allotey, K. I. E. Snell, C. Chan, L. C. Chappell, R. Hooper, M. Green, B. W. Mol, B. Thilaganathan, S. Thangaratinam, and on behalf of the IPPIC Network, Prediction of pre-eclampsia: Review of reviews, Ultrasound Obstet. Gynecol. 54(1) (2019) 16–27; https://doi.org/10.1002/uog.20117
- K. Duckitt and D. Harrington, Risk factors for pre-eclampsia at antenatal booking: Systematic review of controlled studies, BMJ 330(7491) (2005) Article ID 565 (7 pages); https://doi.org/10.1136/bmj.38380.674340.E0
- E. Bartsch, K. E. Medcalf, A. L. Park and J. G. Ray, Clinical risk factors for pre-eclampsia determined in early pregnancy: Systematic review and meta-analysis of large cohort studies, BMJ (2016) Article ID i1753 (10 pages); https://doi.org/10.1136/bmj.i1753
- T. Abraham and A. M. P. Romani, The relationship between obesity and pre-eclampsia: Incidental risks and identification of potential biomarkers for pre-eclampsia, Cells 11(9) (2022) Article ID 1548 (24 pages); https://doi.org/10.3390/cells11091548
- X. Gong, J. Li, Y. Jiang, P. Yuan, L. Chen, Y. Yang, Y. Li, M. Sun, Y. Zhao, H. Shi and Y. Wei, Risk of preeclampsia by gestational weight gain in women with varied prepregnancy BMI: A retrospective cohort study, Front. Endocrinol. 13 (2022) Article ID 967102 (9 pages); https://doi.org/10.3389/fendo.2022.967102
- C. Beck, A. Allshouse, R. M. Silver, W. A. Grobman, H. Simhan, D. Haas, U. M. Reddy and N. R. Blue, High early pregnancy body mass index is associated with alterations in first- and second--trimester angiogenic biomarkers, Am. J. Obstet. Gynecol. MFM 4(3) (2022) Article ID 100614 (10 pages); https://doi.org/10.1016/j.ajogmf.2022.100614
- A. Karge, L. Desing, B. Haller, J. U. Ortiz, S. M. Lobmaier, B. Kuschel and O. Graupner, Performance of sFlt-1/PIGF ratio for the prediction of perinatal outcome in obese pre-eclamptic women, JCM 11(11) (2022) Article ID 3023 (13 pages); https://doi.org/10.3390/jcm11113023
- G. Dekker and B. Sibai, Primary, secondary, and tertiary prevention of pre-eclampsia, The Lancet 357(9251) (2001) 209–215; https://doi.org/10.1016/S0140-6736(00)03599-6
- R. Skjærven, A. J. Wilcox and R. T. Lie, The interval between pregnancies and the risk of preeclampsia, N. Engl. J. Med. 346(1) (2002) 33–38; https://doi.org/10.1056/NEJMoa011379
- Y. Bdolah, U. Elchalal, S. Natanson-Yaron, H. Yechiam, T. Bdolah-Abram, C. Greenfield, D. Goldman-Wohl, A. Milwidsky, S. Rana, S. A. Karumanchi, S. Yagel and D. Hochner-Celnikier, Relationship between nulliparity and preeclampsia may be explained by altered circulating soluble fms-like tyrosine kinase 1, Hypertension in Pregnancy 33(2) (2014) 250–259; https://doi.org/10.3109/10641955.2013.858745
- M. S. Lee, D. Cantonwine, S. E. Little, T. F. McElrath, S. I. Parry, K.-H. Lim and L. E. Wilkins-Haug, Angiogenic markers in pregnancies conceived through in vitro fertilization, Am. J. Obstet. Gynecol. 213(2) (2015) 212.e1-212.e8; https://doi.org/10.1016/j.ajog.2015.03.032
- G. Scott, T. E. Gillon, A. Pels, P. Von Dadelszen and L. A. Magee, Guidelines – similarities and dissimilarities: A systematic review of international clinical practice guidelines for pregnancy hypertension, Am. J. Obstet. Gynecol. 226(2) (2022) S1222–S1236; https://doi.org/10.1016/j.ajog.2020.08.018
- G. Chen, Y. Chen, Y. Shi, Z. Mao, J. Lou and J. Ma, A dynamic prediction model for preeclampsia using the sFlt-1/PLGF ratio combined with multiple factors, BMC Pregnancy Childbirth 24(1) (2024) Article ID 443 (10 pages); https://doi.org/10.1186/s12884-024-06627-4